NCT07184047 2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
Clinical Trials
103 trialsNCT07413146 2026-02-17
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
Sun Yat-sen University
Phase NA Not yet recruiting
NCT03748485 2026-01-28
CANWATCH
Sixth Affiliated Hospital, Sun Yat-sen University
Phase NA Recruiting
NCT06052332 2025-12-05
SHAPERS
Jules Bordet Institute
Phase NA Recruiting
NCT07188025 2025-09-23
REACT
Erasmus Medical Center
Phase 3 Not yet recruiting
NCT00766142 2025-08-29
COCHISE
Institut Bergonié
Phase 2 Terminated
NCT01815853 2025-07-03
Neo-CRAG
Sun Yat-sen University
Phase 3 Completed
NCT06646445 2025-06-13
PREMICES
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Not yet recruiting
NCT00059930 2025-03-26
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT06792149 2025-01-24
Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
Peking Union Medical College Hospital
Recruiting
NCT06775652 2025-01-15
ESCC
Sichuan Cancer Hospital and Research Institute
Phase 3 Completed
NCT05456165 2024-12-31
Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
Gritstone bio, Inc.
Phase 2 Withdrawn
NCT03228043 2024-11-14
Apatinib for Resectable Colorectal Cancer
Nanchong Central Hospital
Phase NA Withdrawn
NCT03673072 2024-11-12
GAIN
Krankenhaus Nordwest
Phase 3 Completed
NCT06520683 2024-11-07
SMALLER
Sun Yat-sen University
Phase 3 Recruiting
NCT05496491 2024-10-08
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
Larissa University Hospital
Phase NA Recruiting
NCT06609551 2024-09-24
ZJCH-CRCC-1
Zhejiang Cancer Hospital
Phase 3 Recruiting
NCT06369480 2024-04-17
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
Recruiting
NCT06208436 2024-01-17
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Unknown
NCT03135652 2024-01-03
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Withdrawn
NCT04308837 2023-11-14
A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
Icahn School of Medicine at Mount Sinai
Phase 2 Unknown
NCT00089024 2023-09-29
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
University of Nebraska
Phase 2 Completed
NCT02676349 2023-09-28
Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)
Institut de Cancérologie de Lorraine
Phase 2 Active not recruiting
NCT00049348 2023-06-15
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT05679583 2023-01-11
Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer
Yonsei University
Phase 2 Recruiting
NCT04755907 2022-07-19
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Peking Union Medical College Hospital
Unknown
NCT01137123 2022-03-31
Improve the Treatment of Thoracic Esophageal Cancer
Sun Yat-sen University
Phase 3 Completed
NCT05194878 2022-01-18
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
Sun Yat-sen University
Phase 3 Recruiting
NCT00010166 2021-09-09
Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas
Wake Forest University Health Sciences
Phase 2 Completed
NCT04664504 2021-06-08
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
ChineseAMS
Phase 2 Unknown
NCT04513457 2021-03-29
Chemotherapy for Resectable Colorectal Liver Metastases
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Completed
NCT00002883 2021-02-23
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
UNICANCER
Phase 3 Completed
NCT04747951 2021-02-15
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
Phase 4 Unknown
NCT04737551 2021-02-04
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study
Shanghai Zhongshan Hospital
Unknown
NCT04595929 2020-11-25
GASPACCO
St. Petersburg State Pavlov Medical University
Phase NA Recruiting
NCT01107639 2020-10-20
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
Swiss Cancer Institute
Phase 3 Completed
NCT00541112 2020-02-11
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
UNICANCER
Phase 2 Terminated
NCT04198051 2019-12-13
The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer
The First Affiliated Hospital of Dalian Medical University
Phase NA Unknown
NCT01314027 2019-07-25
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
University of Zurich
Phase 3 Terminated
NCT01047969 2019-06-13
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT03899870 2019-04-02
Factors Predicting Recurrence in Rectal Cancer After Surgery
Université de Sousse
Completed
NCT03213444 2019-02-15
Impact of Adjuvant Chemotherapy in Patients With Colon Cancer
University of Sao Paulo General Hospital
Phase NA Completed
NCT00493025 2018-12-06
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT02404753 2018-09-28
REALIZATION
Peking University
Phase 2 Unknown
NCT03177382 2018-05-08
TNTCRT
West China Hospital
Phase 3 Unknown
NCT00625183 2017-11-17
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00030563 2017-04-17
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
University of Washington
Phase 2 Completed
NCT00002842 2017-04-11
Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
City of Hope Medical Center
Phase 2 Completed
NCT00550563 2017-04-04
DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements
Roswell Park Cancer Institute
Phase NA Completed
NCT00536874 2017-03-16
Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Memorial Sloan Kettering Cancer Center
Phase 2 Completed